Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 164

1.

Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II.

Stauss HM, Zhu YC, Redlich T, Adamiak D, Mott A, Kregel KC, Unger T.

J Cardiovasc Risk. 1994 Oct;1(3):255-62.

PMID:
7621306
[PubMed - indexed for MEDLINE]
2.

Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.

Hu K, Gaudron P, Anders HJ, Weidemann F, Turschner O, Nahrendorf M, Ertl G.

Cardiovasc Res. 1998 Aug;39(2):401-12.

PMID:
9798525
[PubMed - indexed for MEDLINE]
Free Article
3.

Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.

Benetos A, Levy BI, Lacolley P, Taillard F, Duriez M, Safar ME.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3196-201.

PMID:
9409311
[PubMed - indexed for MEDLINE]
Free Article
4.

The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.

Hartman JC.

Ann Thorac Surg. 1995 Sep;60(3):789-92.

PMID:
7545893
[PubMed - indexed for MEDLINE]
5.

Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.

Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA.

J Clin Invest. 1997 Apr 15;99(8):1926-35.

PMID:
9109437
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.

Wollert KC, Studer R, Doerfer K, Schieffer E, Holubarsch C, Just H, Drexler H.

Circulation. 1997 Apr 1;95(7):1910-7.

PMID:
9107180
[PubMed - indexed for MEDLINE]
Free Article
7.

Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.

Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H.

Circulation. 1994 May;89(5):2273-82.

PMID:
8181153
[PubMed - indexed for MEDLINE]
8.

Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.

Pitt B, Chang P, Timmermans PB.

Cardiovasc Drugs Ther. 1995 Oct;9(5):693-700. Review.

PMID:
8573552
[PubMed - indexed for MEDLINE]
9.

Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content.

Smits JF, van Krimpen C, Schoemaker RG, Cleutjens JP, Daemen MJ.

J Cardiovasc Pharmacol. 1992;20(5):772-8.

PMID:
1280740
[PubMed - indexed for MEDLINE]
10.
11.
12.

Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.

[No authors listed]

Prescrire Int. 2005 Oct;14(79):180-6.

PMID:
16285075
[PubMed - indexed for MEDLINE]
13.

AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats.

Walther T, Siems WE, Hauke D, Spillmann F, Dendorfer A, Krause W, Schultheiss HP, Tschöpe C.

FASEB J. 2002 Aug;16(10):1237-41.

PMID:
12153991
[PubMed - indexed for MEDLINE]
Free Article
14.

Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.

Farhy RD, Carretero OA, Ho KL, Scicli AG.

Circ Res. 1993 Jun;72(6):1202-10.

PMID:
7684331
[PubMed - indexed for MEDLINE]
Free Article
15.

Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction.

Duncan AM, Burrell LM, Kladis A, Campbell DJ.

J Cardiovasc Pharmacol. 1996 Dec;28(6):746-54.

PMID:
8961071
[PubMed - indexed for MEDLINE]
16.
17.

Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms.

Schwieler JH, Kahan T, Nussberger J, Hjemdahl P.

Am J Physiol. 1993 Apr;264(4 Pt 1):E631-7.

PMID:
8386457
[PubMed - indexed for MEDLINE]
18.

Chronic effects of ACE-inhibition (quinapril) and angiotensin-II-type-1 receptor blockade (losartan) on atrial natriuretic peptide in brain nuclei of rats with experimental myocardial infarction.

Hu K, Bahner U, Gaudron P, Palkovits M, Ring M, Fehle A, Kruse B, Ertl G.

Basic Res Cardiol. 2001 May-Jun;96(3):258-66.

PMID:
11403419
[PubMed - indexed for MEDLINE]
19.

Survival after myocardial infarction in rats: captopril versus losartan.

Milavetz JJ, Raya TE, Johnson CS, Morkin E, Goldman S.

J Am Coll Cardiol. 1996 Mar 1;27(3):714-9.

PMID:
8606287
[PubMed - indexed for MEDLINE]
Free Article
20.

Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.

Cruden NL, Witherow FN, Webb DJ, Fox KA, Newby DE.

Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1043-8. Epub 2004 Apr 22.

PMID:
15105283
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk